Statistics

Total Visits

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis70

Select a period of time:

Number of views in the range

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis13

Views

Views
October 20255
November 20256
December 20250
January 20261
February 20261
March 20260
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom4
Brazil2
Mexico2
Argentina2
Finland1
France1
United States1
 

Top cities views

Views
Ciudad Juárez1
Helsinki1
José C. Paz1
Maricá1
Ponta Grossa1
Posadas1
Xalapa1